FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetesPRNewsWire • 09/03/20
COVID-19 Treatments: Remdesivir Disappoints, Antiviral SPL7013 And Monoclonal Antibodies Interesting For Prevention/Early-Stage TreatmentSeeking Alpha • 08/27/20
New England Journal of Medicine Publishes Phase 1/2 Data for Retevmo™ (selpercatinib) in Advanced RET-Driven Lung and Thyroid CancersPRNewsWire • 08/27/20
Blueprint Maintains Independence, Roche Gets Competitor for Eli Lilly Drug in $775 Million DealGuruFocus • 08/24/20
Eli Lilly Expands Pact With China Partner, Bringing Lymphoma Drug To U.S.Investors Business Daily • 08/18/20
Innovent and Lilly Announce Expansion of TYVYT® (Sintilimab Injection) Licensing AgreementPRNewsWire • 08/18/20
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?The Motley Fool • 08/15/20
Innovent and Eli Lilly Announce Acceptance of a Supplemental New Drug Application of TYVYT® (Sintilimab Injection) in Combination with Gemcitabine and Platinum as First-Line Therapy in Squamous Non-Small Cell Lung Cancer in ChinaPRNewsWire • 08/12/20